| [1] | Shipeng MA, Yanqing YU, Xiaoping WU, Liang WANG, Liping LIU, Yuliang ZHANG, Xin WAN, Shanfei GE. Changes in renal function in chronic hepatitis B patients treated initially with entecavir versus tenofovir alafenamide fumarate and related influencing factors[J]. Journal of Clinical Hepatology, 2025, 41(1): 44-51. doi: 10.12449/JCH250107 |
| [2] | Xinxin RONG, Yuanyuan XU, Guangde YANG, Xia WANG, Juanjuan FU, Li LI, Xiucheng PAN. Efficacy and safety of tenofovir alafenamide fumarate in patients with first-time hepatitis B virus-related decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(10): 2008-2013. doi: 10.12449/JCH241013 |
| [3] | Journal of Viral Hepatitis｜Efficacy and safety of tenofovir amibufenamide and tenofovir alafenamide for first-time HBV-related decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2024, 40(12): 2449-2449. doi: 10.12449/JCH2412.gwqkjpwzjj3 |
| [4] | Hepatology International｜Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection[J]. Journal of Clinical Hepatology, 2023, 39(5): 1143-1143. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj2 |
| [5] | Yuwen SONG, Lili SHA, Lizhen CHEN, Mengkun LI, Yurong WANG, Yongning XIN. Research advances in tenofovir alafenamide fumarate in treatment of special chronic hepatitis B[J]. Journal of Clinical Hepatology, 2023, 39(1): 156-161. doi: 10.3969/j.issn.1001-5256.2023.01.024 |
| [6] | Yuwen SONG, Lizhen CHEN, Wenwen JIN, Ning GENG, Yang ZHANG, Shuixian DU, Bentian ZHAO, Jianping DUAN, Yong ZHOU, Chunhua BI, Lei MA, Xinxin HU, Jihong ZHANG, Jiantao SUN, Jie TAN, Yongning XIN. Efficacy and safety of tenofovir alafenamide fumarate in treatment of chronic hepatitis B patients aged ≥60 years in Qingdao, China[J]. Journal of Clinical Hepatology, 2023, 39(5): 1061-1069. doi: 10.3969/j.issn.1001-5256.2023.05.010 |
| [7] | Rui LU, Shuangsuo DANG, Yixin LIU, Yikai WANG, Chenrui LIU, Yaping LI, Fengping WU, Mei LI. Dynamic changes of serum hepatitis B virus DNA and HBsAg in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate for 3 years[J]. Journal of Clinical Hepatology, 2022, 38(10): 2224-2229. doi: 10.3969/j.issn.1001-5256.2022.10.006 |
| [8] | Hailin CHENG, Xudong HU, Bing XIA, Tao BAI, Sixia LU. Clinical effect of tenofovir alafenamide fumarate on chronic hepatitis B patients with low viral load after entecavir treatment[J]. Journal of Clinical Hepatology, 2022, 38(3): 537-540. doi: 10.3969/j.issn.1001-5256.2022.03.009 |
| [9] | Zhao Fei, Liu Fei, Wang ZhongFeng, Li HaiJun, Xu HongMei. Vertical transmission of hepatitis B virus: Modes and blocking strategies[J]. Journal of Clinical Hepatology, 2019, 35(11): 2557-2560. doi: 10.3969/j.issn.1001-5256.2019.11.037 |
| [10] | Wang SuNa, Lian JianQi, Jia ZhanSheng, Zhang Ying. Research advances in the clinical effect of tenofovir alafenamide in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2019, 35(8): 1828-1833. doi: 10.3969/j.issn.1001-5256.2019.08.040 |
| [11] | Zhang JiaWei, Geng JiaBao, Lu Feng, Dong Yu. Clinical effect of tenofovir disoproxil fumarate versus entecavir in treatment of treatment-naïve patients with chronic HBV infection[J]. Journal of Clinical Hepatology, 2018, 34(2): 272-275. doi: 10.3969/j.issn.1001-5256.2018.02.011 |
| [12] | Zhang Kai, Lin ShuMei, Yang XueLiang, Kong Ying, Liu XiaoJing, Zhang Xi, Shi Lei, Chen YunRu, Ye Feng, Li Na. Research advances in paternal- fetal vertical transmission during HBV infection[J]. Journal of Clinical Hepatology, 2016, 32(3): 579-583. doi: 10.3969/j.issn.1001-5256.2016.03.040 |
| [15] | Sun WeiHui, Chu LeiLei, Liu WeiLin, Hao AnHua, Ma Lei, Wan Qiang, Ren Rong, Xin YongNing. Efficacy and safety of telbivudine in preventing mother-to-infant transmission of HBV in pregnant women with high HBV DNA load[J]. Journal of Clinical Hepatology, 2013, 29(8): 596-599. doi: 10.3969/j.issn.1001-5256.2013.08.011 |
| [16] | Huang YanWu, Yin JunFeng, Han FengJuan. Research progress in understanding the mechanisms and interruption of vertical transmission of hepatitis B virus[J]. Journal of Clinical Hepatology, 2012, 28(12): 959-961. |
| [17] | Chen XiaoQin, Yao ZhanCheng, Wu LiPing, Chen MingChun, Zhang YanPing, Wu Yi. Clinical study on telbivudine in preventing mother-to-infant HBV transmission during the late pregnancy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1282-1284. |
DownLoad: